These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 29316191)

  • 1. Microbiota and the liver.
    Shen TD; Pyrsopoulos N; Rustgi VK
    Liver Transpl; 2018 Apr; 24(4):539-550. PubMed ID: 29316191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis.
    de Faria Ghetti F; Oliveira DG; de Oliveira JM; de Castro Ferreira LEVV; Cesar DE; Moreira APB
    Eur J Nutr; 2018 Apr; 57(3):861-876. PubMed ID: 28875318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal immunosuppressor induces stable gut microbiota after liver transplantation.
    Jiang JW; Ren ZG; Lu HF; Zhang H; Li A; Cui GY; Jia JJ; Xie HY; Chen XH; He Y; Jiang L; Li LJ
    World J Gastroenterol; 2018 Sep; 24(34):3871-3883. PubMed ID: 30228781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal microbiota in liver disease.
    Haque TR; Barritt AS
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):133-42. PubMed ID: 27048904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota, Liver Diseases, and Alcohol.
    Cassard AM; Gérard P; Perlemuter G
    Microbiol Spectr; 2017 Aug; 5(4):. PubMed ID: 28840806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of gut microbiota in liver disease.
    Albhaisi SAM; Bajaj JS; Sanyal AJ
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G84-G98. PubMed ID: 31657225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Liver diseases: The pathogenetic role of the gut microbiome and the potential of treatment for its modulation].
    Aitbaev KA; Murkamilov IT; Fomin VV
    Ter Arkh; 2017; 89(8):120-128. PubMed ID: 28914862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature.
    Milosevic I; Vujovic A; Barac A; Djelic M; Korac M; Radovanovic Spurnic A; Gmizic I; Stevanovic O; Djordjevic V; Lekic N; Russo E; Amedei A
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota changes and chronic hepatitis C virus infection.
    Preveden T; Scarpellini E; Milić N; Luzza F; Abenavoli L
    Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):813-819. PubMed ID: 28621554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The gut microbiome is important in chronic liver disease].
    Christensen E
    Ugeskr Laeger; 2019 Jan; 181(2):. PubMed ID: 30618372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gut microbiome.
    Sidhu M; van der Poorten D
    Aust Fam Physician; 2017; 46(4):206-211. PubMed ID: 28376573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of gut microbiota in chronic liver diseases, and treatment possibilities].
    Hagymási K; Bacsárdi A; Egresi A; Berta E; Tulassay Z; Lengyel G
    Orv Hetil; 2018 Sep; 159(36):1465-1474. PubMed ID: 30175608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics.
    Cho MS; Kim SY; Suk KT; Kim BY
    J Microbiol; 2018 Dec; 56(12):855-867. PubMed ID: 30377993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Intestinal Microbiome and the Liver Transplant Recipient: What We Know and What We Need to Know.
    Doycheva I; Leise MD; Watt KD
    Transplantation; 2016 Jan; 100(1):61-8. PubMed ID: 26647107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease Progression.
    Mungamuri SK; Vijayasarathy K
    Crit Rev Oncog; 2020; 25(1):57-70. PubMed ID: 32865911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH).
    Duarte SMB; Stefano JT; Oliveira CP
    Ann Hepatol; 2019; 18(3):416-421. PubMed ID: 31036494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiome and liver diseases.
    Tilg H; Cani PD; Mayer EA
    Gut; 2016 Dec; 65(12):2035-2044. PubMed ID: 27802157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The intestinal microbiota as a therapeutic target in the treatment of NAFLD and ALD.
    Huang W; Kong D
    Biomed Pharmacother; 2021 Mar; 135():111235. PubMed ID: 33561650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the gut microbiome in graft fibrosis after pediatric liver transplantation.
    Qin T; Fu J; Verkade HJ
    Hum Genet; 2021 May; 140(5):709-724. PubMed ID: 32920649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota and health.
    Kc D; Sumner R; Lippmann S
    Postgrad Med; 2020 Apr; 132(3):274. PubMed ID: 31566046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.